Literature DB >> 8384985

Coupons attract high-risk untreated heroin users into detoxification.

J L Sorensen1, M F Costantini, T L Wall, D R Gibson.   

Abstract

This study examined the degree that the distribution of coupons brought drug users at risk of HIV infection into outpatient detoxification treatment. Demographic characteristics and outcome indicators were compared for patients recruited through coupon redemption (n = 238) versus other referral channels (n = 1129). Significantly more coupon subjects had no previous drug treatment, compared with non-coupon subjects (28% vs. 13%), had shared needles in the previous 30 days (39% vs. 31%) and more were ethnic minorities and men. Length of treatment stay and program completion rates did not differ between the groups. Within a year of the coupon project's end 43% of coupon subjects returned to the treatment program. Results suggest untreated heroin users will utilize drug treatment if more is available.

Entities:  

Mesh:

Year:  1993        PMID: 8384985     DOI: 10.1016/0376-8716(93)90007-d

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  3 in total

1.  Facilitating treatment entry among out-of-treatment injection drug users.

Authors:  R E Booth; C Kwiatkowski; M Y Iguchi; F Pinto; D John
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

2.  Challenges in motivating treatment enrollment in community syringe exchange participants.

Authors:  Michael Kidorf; Elizabeth Disney; Van King; Ken Kolodner; Peter Beilenson; Robert K Brooner
Journal:  J Urban Health       Date:  2005-07-13       Impact factor: 3.671

3.  The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Authors:  August F Holtyn; Mikhail N Koffarnus; Anthony DeFulio; Sigurdur O Sigurdsson; Eric C Strain; Robert P Schwartz; Jeannie-Marie S Leoutsakos; Kenneth Silverman
Journal:  Prev Med       Date:  2014-03-04       Impact factor: 4.018

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.